Diagnostic Labs for Sale and Investment

• Chain of diagnostic laboratories with operations across Mumbai, Haldia (West Bengal), Assam, Bihar, and Panipat, providing comprehensive pathology and laboratory testing services. • Operates a network of 7 laboratories, of which 3 are NABL-accredited, offering biochemistry, hematology, immunoassay, coagulation, and other diagnostic testing services. • Established pathology brand with over 20 years of operating history and a strong reputation for quality diagnostic services. • Equipped with fully automated, high-end modular analyzers from Roche, enabling efficient and accurate sample processing. • Processes more than 1,000 diagnostic samples daily through an extensive referral network and institutional partnerships. • Serves over 300 referring doctors, approximately 500 B2B laboratory partners, and 10 major hospitals, providing a diversified and recurring client base. • Generates annual revenue of approximately INR 10 crore and operates as a profitable business. • Well positioned for expansion by increasing laboratory capacity, strengthening institutional partnerships, and expanding its diagnostic service offerings.

Patient-focused diagnostic centre established 4 years ago in Chennai, offering a comprehensive range of diagnostic and imaging services under one roof. - Provides ultrasound, echocardiography (Echo), X-ray, ECG, and pathology laboratory testing, with all diagnostic tests conducted in-house for faster turnaround and quality control. - Serves approximately 30–40 walk-in patients daily, supported by a growing local patient base and referral network. - Operates with a team of 4 employees managing diagnostic services, laboratory operations, and patient care.

The startup is in the pre-revenue, pre-launch stage. - The business is incorporated as a C-Corporation in the State of Delaware, but the acquired laboratory facility is located in Tampa, Florida, where the operations will be based. - One of the two co-founders is currently based in New York, NY, and the other in Chicago, IL. - The co-founders have developed and validated a highly innovative platform technology that enables delivery of a cancer diagnostic test providing therapy guidance across multiple cancer types and treatment modalities, including surgery, radiation, chemotherapy, immunotherapy, and targeted therapy. - The total addressable market (TAM) in the U. S. is approximately $3.6B, with a serviceable available market (SAM) of $2.3B and a serviceable obtainable market (SOM) of $90–116M at full platform scale. - For the U. S. market, the company plans to drive sales and marketing efforts targeting both patients and their physicians. - For international markets, particularly the EU, Latin America, Gulf/MENA, and Southeast Asia, the company intends to engage distribution partners. - In less developed markets, distribution will be managed directly through professional networks and online sales programs targeting patients and physicians. - The co-founder brings extensive experience in life sciences and diagnostics investment banking, having led multiple mergers, acquisitions, and corporate transactions in the diagnostics sector. He is also the architect of the multi-stack AI reporting system that provides a key competitive advantage. - The technical co-founder has over 15 years of experience in NIH-funded cancer research (SBIR Phase I & II awardee) and has developed the core test paradigm and proprietary predictive algorithms that form the foundation of the platform.

The business is a diagnostic centre located in Taloja Phase 1, Navi Mumbai. - It has built a strong reputation within the local community for reliable and affordable diagnostic services. - Pathology testing is the top-selling service and accounts for the majority of patient visits. - The centre receives 25–30 walk-in patients daily.

Operates a B2B pathology laboratory based in Delhi, offering routine and specialized blood testing services. - Serves hospitals, clinics, and diagnostic labs through a B2B referral-based model. - Maintains a strong network with 450+ active customers and an overall base of around 800+ customers. - Provides a wide range of diagnostic services, ensuring consistent demand from healthcare providers. - Differentiates through regulatory compliance in a market with many unregulated players. - Generates recurring business through repeat testing requirements from partner institutions. - Holds ISO and NABL accreditations, ensuring high standards of quality, accuracy, and reliability. - Positioned for growth through expansion of test offerings and strengthening institutional partnerships.

Primary diagnostic laboratory offering routine medical testing services with full operational licensing. - Holds complete accreditation from the Department of Health (DOH) and Local Government Unit (LGU). - Provides essential diagnostic services including blood chemistry testing, drug screening, health certificates, annual physical exams, and pre-employment medical tests. - Drug testing services support compliance needs for employment screening and institutional requirements. - Serves manpower agencies and employment-related clients requiring medical clearance and certification. - Also authorized for stool and sputum examinations under QC health and sanitary certification. - Operates as a primary laboratory with the infrastructure and approvals required for regulated diagnostic services. - Currently operates without active marketing, presenting clear growth potential through outreach to corporate clients and recruitment agencies. </pre>